Vitamin D suppletion and aspecific musculo-skeletal disorders

Vitamin D suppletion and aspecific musculo-skeletal disorders - -

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON33615

Enrollment

Registered

2008-01-11

Start date

2008-02-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

musculo-skeletal disorders widespread pain

Interventions

1 or 2 times 150.000 IU cholecalciferol

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: asian or african origin 18-60 yrs > 6wk complaininig of muscle-pain or weakness

Exclusion criteria

Exclusion criteria: Specific diseases causing musclepain like polymyalgia rheumatica, arthritis (depression or fibromyalgia or somatisationdisorder are no exclusion-criteria) use of statines or ciclosporine use of vit D suppletion in the past 4 months ESR > 30, Kreat > 150 mmol/L sarcoidose, TBC

Design outcomes

Primary

Measure	Time frame
difference in complaints between inclusion date and 6 weeks after 150.000 IU cholecalciferol or 300.000 IU	—

Secondary

Measure	Time frame
difference in complaints between inclusion date and 12 weeks after 150.000 IU cholecalciferol (or placebo) difference in improvement in localisation of complaints vit D level on inclusion vit D level at 12 weeks difference in vit D levels wee12 and on inclusion with 150.000 or 300.000 IU	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)